Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis (Q56892087)
Jump to navigation
Jump to search
scientific article published on 01 March 1995
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis |
scientific article published on 01 March 1995 |
Statements
Guidelines for clinical trials in systemic sclerosis (scleroderma). I. Disease-modifying interventions. The American College of Rheumatology Committee on Design and Outcomes in Clinical Trials in Systemic Sclerosis (English)
B White
E A Bauer
M C Hochberg
L M Katz
J H Korn
E C LeRoy
M P Mitrane
1 March 1995